A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the progression of type 1 diabetes (T1D).

Eight children with severe autoimmune diseases who did not respond to conventional therapies were able to completely stop ...

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Nonresponse to bridging therapy and high lymphocyte count were predictive of parkinsonism and nonrelapse mortality (NRM) after treatment with ciltacabtagene autoleucel (cilta-cel; Carvykti) in ...

Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted ...

Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...

Genmab A/S (GMAB) said on Friday that its late-stage trial evaluating drug Epcoritamab demonstrated an improvement in progression-free survival in certain patients with relapsed or refractory (R/R) ...

Dave Coulier has confirmed he is now in remission, and his update has offered relief to fans worldwide. The longtime acotor ...

Using single-cell epigenomic profiling of immune cells from 110 individuals, researchers show that genetic variation and ...